Professional business directory

Find the best businesses and services near you. Discover verified companies across all industries.

Category: treatment

treatment Sep 18

LITAK 2 MG/ML INJ FL 5 ML (Cladribine)

LITAK 2 MG/ML INJ FL 5 ML (Cladribine) - Maladie rare sans désignation orpheline Treatment of hai

View Details
treatment Sep 18

NOVOEIGHT 1 000 UI INJ FL + SRG (Turoctocog alfa)

NOVOEIGHT 1 000 UI INJ FL + SRG (Turoctocog alfa) - Maladie rare sans désignation orpheline Treat

View Details
treatment Sep 18

NOVOEIGHT 1 500 UI INJ FL + SRG (Turoctocog alfa)

NOVOEIGHT 1 500 UI INJ FL + SRG (Turoctocog alfa) - Maladie rare sans désignation orpheline Treat

View Details
treatment Sep 18

NOVOEIGHT 2 000 UI INJ FL + SRG (Turoctocog alfa)

NOVOEIGHT 2 000 UI INJ FL + SRG (Turoctocog alfa) - Maladie rare sans désignation orpheline Treat

View Details
treatment Sep 18

NOVOEIGHT 250 UI INJ FL + SRG (Turoctocog alfa)

NOVOEIGHT 250 UI INJ FL + SRG (Turoctocog alfa) - Maladie rare sans désignation orpheline Treatme

View Details
treatment Sep 18

NOVOEIGHT 3 000 UI INJ FL + SRG (Turoctocog alfa)

NOVOEIGHT 3 000 UI INJ FL + SRG (Turoctocog alfa) - Maladie rare sans désignation orpheline Treat

View Details
treatment Sep 18

NOVOEIGHT 500 UI INJ FL + SRG (Turoctocog alfa)

NOVOEIGHT 500 UI INJ FL + SRG (Turoctocog alfa) - Maladie rare sans désignation orpheline Treatme

View Details
treatment Sep 18

MABTHERA 100 MG PERF FL 10 ML (Rituximab)

MABTHERA 100 MG PERF FL 10 ML (Rituximab) - Maladie rare sans désignation orpheline * Non-Hodgkin

View Details
treatment Sep 18

MABTHERA 500 MG PERF FL 50 ML (Rituximab)

MABTHERA 500 MG PERF FL 50 ML (Rituximab) - Maladie rare sans désignation orpheline * Non-Hodgkin

View Details
treatment Sep 18

HUMIRA 40 MG INJ FL 0,8 ML + NEC (Adalimumab)

HUMIRA 40 MG INJ FL 0,8 ML + NEC (Adalimumab) - Maladie rare sans désignation orpheline *In combi

View Details
treatment Sep 18

HUMIRA 40 MG INJ SRG 0,8 ML + T (Adalimumab)

HUMIRA 40 MG INJ SRG 0,8 ML + T (Adalimumab) - Maladie rare sans désignation orpheline *In combin

View Details
treatment Sep 18

HUMIRA 40 MG INJ STYLO 0,8 ML + T (Adalimumab)

HUMIRA 40 MG INJ STYLO 0,8 ML + T (Adalimumab) - Maladie rare sans désignation orpheline *In comb

View Details